Search

everythinglearnresearchcommunity

for

Search:↓

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Adalimumab improved folliculitis decalvans in most patients.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The combination therapy was effective and well-tolerated, especially in young patients.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.